Cargando…

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity

Current anti-HBV therapeutic strategy relies on interferon and nucleos(t)ide-type drugs with the limitation of functional cure, inducing hepatitis B surface antigen (HBsAg) loss in very few patients. Notably, the level of HBsAg has been established as an accurate indicator to evaluate the drug effic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Si-Yu, Yu, Hai-Bo, Yang, Zhen, Qin, Yi-Ping, Ren, Ji-Hua, Cheng, Sheng-Tao, Ren, Fang, Law, Betty Yuen Kwan, Wong, Vincent Kam Wai, Ng, Jerome P. L., Zhou, Yu-Jiao, He, Xin, Tan, Ming, Zhang, Zhen-Zhen, Chen, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204083/ https://www.ncbi.nlm.nih.gov/pubmed/35721154 http://dx.doi.org/10.3389/fphar.2022.837115

Ejemplares similares

Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model
por: Ge, Fei-lin, et al.
Publicado: (2021)

Enchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replication
por: Gu, Jin-Gang, et al.
Publicado: (2011)

SIRT2 Promotes HBV Transcription and Replication by Targeting Transcription Factor p53 to Increase the Activities of HBV Enhancers and Promoters
por: Wu, Dai-Qing, et al.
Publicado: (2022)

Improved pharmacokinetics of tenofovir ester prodrugs strengthened the inhibition of HBV replication and the rebalance of hepatocellular metabolism in preclinical models
por: Hong, Xiaodan, et al.
Publicado: (2022)

An HBV-encoded miRNA activates innate immunity to restrict HBV replication
por: Zhao, Xiaoqing, et al.
Publicado: (2019)

Bavachin Protects Human Aortic Smooth Muscle Cells Against β-Glycerophosphate-Mediated Vascular Calcification and Apoptosis via Activation of mTOR-Dependent Autophagy and Suppression of β-Catenin Signaling
por: He, Hu-Qiang, et al.
Publicado: (2019)

Heme and HO-1 Inhibition of HCV, HBV, and HIV
por: Schmidt, Warren N., et al.
Publicado: (2012)

A Polysaccharide From Eupolyphaga sinensis Walker With Anti-HBV Activities In Vitro and In Vivo
por: Zhang, Xue, et al.
Publicado: (2022)

Suppression of HBV replication by the expression of nickase- and nuclease dead-Cas9
por: Kurihara, Takeshi, et al.
Publicado: (2017)

The New Application of UHPLC-DAD-TOF/MS in Identification of Inhibitors on β-Amyloid Fibrillation From Scutellaria baicalensis
por: Yu, Lu, et al.
Publicado: (2019)

HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA
por: Chong, Chun Kong, et al.
Publicado: (2020)

Nucleic Acid Testing for the Detection of HBV DNA
por: Seto, Wai Kay, et al.
Publicado: (2011)

HBV replication is significantly reduced by IL-6
por: Kuo, Tzer-Min, et al.
Publicado: (2009)

Advances in HBV infection and replication systems in vitro
por: Xu, Ruirui, et al.
Publicado: (2021)

The Infection Efficiency and Replication Ability of Circularized HBV DNA Optimized the Linear HBV DNA in Vitro and in Vivo
por: Li, Xiaosong, et al.
Publicado: (2015)

ATM and ATR Expression Potentiates HBV Replication and Contributes to Reactivation of HBV Infection upon DNA Damage
por: Kostyusheva, Anastasiya, et al.
Publicado: (2019)

1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection
por: Chen, Rui Hong, et al.
Publicado: (2021)

Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HBV Replication through Production of IFN-γ and TNF-⍺
por: Haque, Mohammad, et al.
Publicado: (2020)

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis
por: Price, Huw, et al.
Publicado: (2013)

Tetrandrine, an Activator of Autophagy, Induces Autophagic Cell Death via PKC-α Inhibition and mTOR-Dependent Mechanisms
por: Wong, Vincent Kam Wai, et al.
Publicado: (2017)

Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication In Vivo
por: Zhu, Wenbo, et al.
Publicado: (2012)

Antibiotic-induced gut bacteria depletion has no effect on HBV replication in HBV immune tolerance mouse model
por: Bu, Yanan, et al.
Publicado: (2023)

ZEB2 inhibits HBV transcription and replication by targeting its core promoter
por: He, Qiao, et al.
Publicado: (2016)

RPB5-Mediating Protein Suppresses Hepatitis B Virus (HBV) Transcription and Replication by Counteracting the Transcriptional Activation of Hepatitis B virus X Protein in HBV Replication Mouse Model
por: Zhou, Qiaoling, et al.
Publicado: (2015)

A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells
por: Han, Yu, et al.
Publicado: (2019)

HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis
por: Dong, Mei-Ling, et al.
Publicado: (2022)

TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells
por: Zhang, Biao, et al.
Publicado: (2018)

Visualizing in situ viral replication across the natural history of chronic HBV infection
por: Zhang, Hanyue, et al.
Publicado: (2023)

Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability
por: Yang, Fangji, et al.
Publicado: (2019)

Comparison of Serum HBsAg Quantitation by Four Immunoassays, and Relationships of HBsAg Level with HBV Replication and HBV Genotypes
por: Tuaillon, Edouard, et al.
Publicado: (2012)

Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication
por: Zhong, L, et al.
Publicado: (2015)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
por: Lu, Hongzhu, et al.
Publicado: (2012)

HBV Infection in HIV-Driven Immune Suppression
por: Sarmati, Loredana, et al.
Publicado: (2019)

Molecular mechanism of hepatitis B virus (HBV) on suppression of raf kinase inhibitor protein (RKIP) expression
por: Cheng, Xiao-Ke, et al.
Publicado: (2016)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges
por: Ge, Feilin, et al.
Publicado: (2023)

Pharmacodynamics and Pharmacokinetics of Injectable Pimobendan and Its Metabolite, O-Desmethyl-Pimobendan, in Healthy Dogs
por: Pichayapaiboon, Poonavit, et al.
Publicado: (2021)

The HBV Core Protein and Core Particle Both Bind to the PPiase Par14 and Par17 to Enhance Their Stabilities and HBV Replication
por: Saeed, Umar, et al.
Publicado: (2021)

Constructing the HBV-human protein interaction network to understand the relationship between HBV and hepatocellular carcinoma
por: Wu, Zhong-Jun, et al.
Publicado: (2010)

Serum neopterin levels in patients with replicative and nonreplicative HBV carriers
por: Kaleli, Ilknur, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_3cj964g84g4b9ue8fcs05a30vh